Related Experiment Video
Updated: Jun 14, 2026
10:33
Phenotypic Profiling of MPTP-Induced Parkinsonian-like Behavioral Phenotypes in Zebrafish Larvae Based on Behavioral Experiment
Published on: May 15, 2026
Parkinson's disease and 2009: recent advances
David P Breen1, Roger A Barker
1Department of Clinical Neurosciences, Cambridge Centre for Brain Repair, University of Cambridge, ED Adrian Building, Forvie Site, Cambridge, UK. davebreen@excite.co.uk
Journal of Neurology
|April 9, 2010
Summary
This review covers Parkinson disease research from the Journal of Neurology in 2009. It highlights key findings and advancements in understanding and managing Parkinson disease.
Area of Science:
- Neurology
- Neuroscience
Background:
- Parkinson disease (PD) is a progressive neurodegenerative disorder.
- Research is crucial for understanding PD pathogenesis and improving patient outcomes.
Purpose of the Study:
- To summarize Parkinson disease (PD) research published in the Journal of Neurology in 2009.
- To provide an overview of key advancements in the field during that year.
Main Methods:
- Literature review of articles published in the Journal of Neurology in 2009.
- Selection of studies specifically related to Parkinson disease (PD).
Main Results:
- The review identifies and synthesizes findings from various PD studies.
- Key research areas covered include diagnosis, treatment, and disease mechanisms.
Conclusions:
- The Journal of Neurology published significant PD research in 2009.
- These studies contributed to the growing body of knowledge on Parkinson disease (PD).
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...